Mehmet Yavuz is 62 yo. He presented to the clinic and after having an HbA1c test (result 9%) was diagnosed with type 2 Diabetes mellitus.His cardiovascular risk was > 15%. His renal health screen showed an eGFR 90 mL/min/1.73m2 with microalbuminuria of 3.5 mg/mmol.He attended a podiatry appointment which detected decreased dorsalis pedis and posterior tibialis pulses in both legs . Management of his condition now includes the following: Exercise: at least 150 minutes of aerobic and 60 minutes of resistance exercise each week Diet: a plan worked out with an accredited dietician based on the Australian Dietary Guidelines (2013). Drug use: smoking cessation plan to stop cigarette use; alcohol consumption reduction to 1 - 2 full strength beers every second day Weight loss: Mehmet aims to lose 5 kg over the first 6 - 8 weeks after diagnosis. Medications: Jardiamet (empagliflozin 5mg, metformin 500 mg), twice daily, with or after food ramipril 5 mg, daily Rosuzet (rosuvastatin 20mg, ezetimibe 10mg), daily. Ongoing diagnostics: HbA1c: every 3 months lipid profile: every 3 months renal function assessment: annually podiatrist assessment: at least once a year optometrist assessment: at least once a year. Question 1: From the TWO (2) therapies to discuss: metformin. rosuvastatin. You need to do the following for each medication: describe the mechanism of ACTION/S identify the AIM of each therapy for Mehmet relate each therapy to Mehmet's pathophysiological presentation refer briefly to any GUIDELINES which support the use of each medication identify one RISK or special consideration for Mehmet whilst taking each medication identify what evidence will demonstrate the EFFECTIVENESS of each therapy

Human Anatomy & Physiology (11th Edition)

11th Edition

ISBN:9780134580999

Author:Elaine N. Marieb, Katja N. Hoehn

Publisher:Elaine N. Marieb, Katja N. Hoehn

Chapter1: The Human Body: An Orientation

Section: Chapter Questions

Problem 1RQ: The correct sequence of levels forming the structural hierarchy is A. (a) organ, organ system,...

See similar textbooks

Related questions

Question

Mehmet Yavuz is 62 yo. He presented to the clinic and after having an HbA1c test (result 9%) was diagnosed with type 2 Diabetes mellitus.His cardiovascular risk was > 15%. His renal health screen showed an eGFR 90 mL/min/1.73m² with microalbuminuria of 3.5 mg/mmol.He attended a podiatry appointment which detected decreased dorsalis pedis and posterior tibialis pulses in both legs .

Management of his condition now includes the following:

Exercise: at least 150 minutes of aerobic and 60 minutes of resistance exercise each week
Diet: a plan worked out with an accredited dietician based on the Australian Dietary Guidelines (2013).
Drug use: smoking cessation plan to stop cigarette use; alcohol consumption reduction to 1 - 2 full strength beers every second day
Weight loss: Mehmet aims to lose 5 kg over the first 6 - 8 weeks after diagnosis.
Medications:
Jardiamet (empagliflozin 5mg, metformin 500 mg), twice daily, with or after food
ramipril 5 mg, daily
Rosuzet (rosuvastatin 20mg, ezetimibe 10mg), daily.

Ongoing diagnostics:

HbA1c: every 3 months
lipid profile: every 3 months
renal function assessment: annually
podiatrist assessment: at least once a year
optometrist assessment: at least once a year.

Question 1: From the TWO (2) therapies to discuss:

metformin.
rosuvastatin.
You need to do the following for each medication:
- describe the mechanism of ACTION/S
- identify the AIM of each therapy for Mehmet
- relate each therapy to Mehmet's pathophysiological presentation
- refer briefly to any GUIDELINES which support the use of each medication
- identify one RISK or special consideration for Mehmet whilst taking each medication
- identify what evidence will demonstrate the EFFECTIVENESS of each therapy